HomeCompareCOPHF vs NOBL

COPHF vs NOBL: Dividend Comparison 2026

COPHF yields 1709.40% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 COPHF wins by $2322151466.34M in total portfolio value
10 years
COPHF
COPHF
● Live price
1709.40%
Share price
$0.12
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2322151466.36M
Annual income
$2,082,500,711,449,475.00
Full COPHF calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — COPHF vs NOBL

📍 COPHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCOPHFNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, COPHF + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
COPHF pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

COPHF
Annual income on $10K today (after 15% tax)
$145,299.15/yr
After 10yr DRIP, annual income (after tax)
$1,770,125,604,732,053.80/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, COPHF beats the other by $1,770,125,604,731,844.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of COPHF + NOBL for your $10,000?

COPHF: 50%NOBL: 50%
100% NOBL50/50100% COPHF
Portfolio after 10yr
$1161075733.19M
Annual income
$1,041,250,355,724,860.60/yr
Blended yield
89.68%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

COPHF buys
0
NOBL buys
0
No recent congressional trades found for COPHF or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCOPHFNOBL
Forward yield1709.40%2.14%
Annual dividend / share$2.00$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$2322151466.36M$22.8K
Annual income after 10y$2,082,500,711,449,475.00$246.19
Total dividends collected$2304918550.89M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: COPHF vs NOBL ($10,000, DRIP)

YearCOPHF PortfolioCOPHF Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$181,640$170,940.17$10,914$214.34+$170.7KCOPHF
2$3,096,187$2,901,831.95$11,897$218.63+$3.08MCOPHF
3$49,540,776$46,227,856.03$12,952$222.72+$49.53MCOPHF
4$744,291,200$691,282,569.33$14,086$226.62+$744.28MCOPHF
5$10,502,651,287$9,706,259,702.90$15,302$230.33+$10502.64MCOPHF
6$139,242,028,591$128,004,191,713.95$16,607$233.85+$139242.01MCOPHF
7$1,735,020,474,520$1,586,031,503,927.80$18,007$237.18+$1735020.46MCOPHF
8$20,326,276,226,909$18,469,804,319,173.38$19,508$240.35+$20326276.21MCOPHF
9$223,972,668,143,395$202,223,552,580,602.00$21,116$243.35+$223972668.12MCOPHF
10$2,322,151,466,362,908$2,082,500,711,449,475.00$22,841$246.19+$2322151466.34MCOPHF

COPHF vs NOBL: Complete Analysis 2026

COPHFStock

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Full COPHF Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this COPHF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

COPHF vs SCHDCOPHF vs JEPICOPHF vs OCOPHF vs KOCOPHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.